Abstract
Inferring the transmission potential of an infectious disease during the low-incidence period following an epidemic wave is crucial for preparedness. In this period, necessarily scarce data hamper existing inference methods, blurring early-warning signals essential for discriminating between the likelihoods of resurgence versus elimination. Advanced insight into whether a region of interest will face elevating caseloads (requiring swift community-wide interventions) or achieve local elimination (allowing interventions to be relaxed or refocussed on controlling the importation of infections), can be the difference between decisive and ineffective policy. We propose a novel early-warning framework that formally maximises information extracted from low-incidence data to robustly infer the chances of sustained local transmission or elimination in real time, at any desired scale of investigation. Applying this framework, we decipher previously hidden disease-transmission signals from the prolonged low-incidence COVID-19 data of New Zealand, Hong Kong and Victoria state, Australia. We uncover how timely interventions averted dangerous, resurgent waves of COVID-19 and support official declarations of elimination. Across these locations, we obtain strong evidence for the effectiveness of rapid and adaptive COVID-19 responses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
KVP and CAD acknowledge joint centre funding from the UK Medical Research Council (MRC) and Department for International Development (DFID) under grant reference MR/R015600/1. CAD thanks the UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections in partnership with Public Health England (PHE) for funding (grant HPRU200907).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Major update to analysis and text. Two additional case-studies: Hong Kong, China and Victoria state, Australia are included (on top of the original New Zealand one). The text is also now fleshed out with more detail and additional investigations (Results and Supplement).
Data Availability
The computational framework introduced in this study forms a major update of the EpiFilter codebase, which is available in R and Matlab at: https://github.com/kpzoo/EpiFilter
